Dr. Brett Daniel Lebed, MD

Dr. Lebed practices at Urology Associates of the Central Coast in San Luis Obispo, California.

Dr. Lebed's NPI, 1962664409, was assigned on June 26, 2008. Dr. Lebed graduated from Lewis Katz School of Medicine in 2002. Dr. Lebed holds California license C55845.

Dr. Lebed's primary practice is Urology Associates of the Central Coast, at 225 Prado Rd, San Luis Obispo, CA 93401 in San Luis Obispo County. The practice phone is (805) 786-2500.

Dr. Lebed's primary practice is Urology Associates of the Central Coast in San Luis Obispo, California. Dr. Lebed is also affiliated with Dignity Health - French Hospital Medical Center. The medical group on file is Urology Associates of the Central Coast. Dmand AI also links Dr. Lebed to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lebed practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Lebed's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Lebed is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Lebed's licenses on file in 3 states: California, Pennsylvania and South Carolina.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney disease, kidney removal surgery and kidney stone disease among the conditions Dr. Lebed treats.

CMS data shows 28,532 Medicare services from Dr. Lebed across 47 procedure codes in 2024, for 2,373 Medicare patients. Medicare paid $786,690 for them.

CMS counts 2,373 Medicare patients who saw Dr. Lebed in 2024. The largest group is 65 to 74, with 988 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lebed's median patient age at 73, with 54% women.

In 2024, Dr. Lebed wrote 6,358 Medicare Part D claims for 1,637 patients. 82% of them were for generic drugs. CMS names the drug for 6,181 of them, across 44 drugs with 11 or more claims each, at $2,704,958 in total drug cost. In 2023, CMS named 5,452 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Lebed for performance year 2024, reported as part of a group. Dr. Lebed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lebed as offering telehealth. CMS counts 12 procedures of removal of the uterus by Dr. Lebed, more than 86% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Lebed, published from 2010 to 2011. 2010 was the busiest year, with 3. The most frequent topics are Suburethral Slings, Urinary Bladder, Overactive and Urinary Incontinence, Stress. Dr. Lebed has published most often in Urology. Dr. Lebed's most frequent co-authors are Robin Rashmi Bhavsar, MD, Daniel J. Canter, MD and Alienor Sylvaine Gilchrist, MD.

CMS Open Payments shows 644 general payments to Dr. Lebed from 66 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $1,636.

Dmand AI lists 1 award for Dr. Lebed, most recently CMS Stage 1 2012 in 2011.

Dr. Lebed graduated from Lewis Katz School of Medicine in 2002.

Dr. Lebed is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.